Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Kyntra Bio, Inc. (FGEN)

Pharmaceutical Preparations

Latest Price

$9.71

TTM P/E

--

Normalized P/E

--

TTM Div Yield

--

Fwd Div Yield

--

Book Value

--

P/B Ratio

--

Valuation metrics

adjust assumptions →

EPS: $45.37

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$680.55

+6909% upside

Institutional Ownership

0.4% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
Connective Capital Management, LLC	15.0K	--	0.37%	--	2025-06-30

View all institutional holders →